Yasmin Islam joins Salus Wellness this month
The team are happy to announce that Yasmin Islam has joined Salus Wellness. Yasmin Islam is an adult nurse registered with the Nursing and Midwifery Council (NMC). She has developed her passion for aesthetic treatments and specialises in non-surgical facial beautification and rejuvenation with the use of dermal fillers, anti-wrinkle injections and fat-dissolving treatments.
Beyond sleep apps: The power of human support in insomnia recovery
Salus Wellness Clinics writes...In the quest for better sleep, a myriad of digital solutions beckon, promising relief from restless nights. Yet, amidst the allure of sleep apps and digital platforms, the age-old remedy of human support shines bright, offering personalized guidance and steadfast empathy in the journey toward better sleep.
Exonate first-in-class eye drop Phase Ib/IIa trial data demonstrate safety and biological activity in treatment of diabetic retinopathy and diabetic macular oedema
EXN407 is the first topical SRPK1 inhibitor to demonstrate both safety and signals of biological response as monotherapy for these indications Data generated fully support continued clinical development of EXN407 into the CLEAR-DM Phase IIb studyConsultant led Cyber Essentials certification
Still considering if Cyber Essentials or Cyber Essentials Plus is the right certification for your business?
SolasCure publishes Phase IIa Clinical Trial Report in leading Wound Care Journal
Publication in the ‘International Wound Journal’ provides robust validation of the Phase IIa trial data that will enable further clinical studies Study demonstrates proof-of-concept and strong safety profile of Aurase Wound Gel in patients suffering from chronic wounTransforming Healthcare Podcast: The importance of collaboration and cooperation in healthcare
In this episode, Dr Bipin Patel reunites with Tony Jones, Chief Executive of One Nucleus, a not-for-profit Life Sciences & Healthcare membership organisation headquartered in Cambridge.
SPT Labtech and RevoluGen demonstrate fully automated Bead-Based High Molecular Weight DNA Extraction
The collaboration delivers a walk-away solution suitable for high-throughput long-read sequencing in under two hours.
Bio-Rad launches Vericheck ddPCR Replication Competent Lentivirus and Replication Competent AAV Kits for cell and gene therapy production
Rapid, Sensitive, and Validated Detection of Viral Replication Genes Using Droplet Digital™ PCR During Cell and Gene Therapy Production
2024 Corazon's Charity of the Year
Corazon Health is delighted to announce that EACH (East Anglia's Children's Hospices) has been chosen as their 2024 Charity of The Year, following a selection process that included a vote by employees.
Optibrium launches a metabolism prediction software platform tailored to DMPK scientists
Semeta™ offers high sensitivity and superior precision for the prediction of Phase I and II metabolic routes, sites, products and liabilities in early drug discovery
CRA Insights: A landscape assessment of newborn screening (NBS) in Europe
Newborn screening (NBS) has become an integral part of many public health programs.1 NBS programs have minimized pati
Jon Hume joins Cuttsy+Cuttsy as New Commercial Director
Cuttsy+Cuttsy is excited to announce the appointment of Jon Hume as Commercial Director, effective 1st March 2024.
TR Events & Catering Announces George Nolan as New Head of Sales
TR Events & Catering, a leading multi-service event management provider in Cambridgeshire and Suffolk, is thrilled to announce the appointment of George Nolan as the new Head of Sales. This appointment is a significant milestone for the company, signalling its continued growth and evolution in the competitive event management industry.
Challenges to a dual: What makes a dual-brand approach viable?
Pharmaceutical and biologic therapies are increasingly demonstrating their effectiveness in the treatment of multiple diseases.
SPT Labtech continues to support UKHSA genomics surveillance project to bolster global health security
Cambridge – SPT Labtech, a global leader in the design, development and manufacture of automated instrumentation and consumables for life science applications, continues its partnership with the UK Health Security Agency (UKHSA)
Launching evolue - hello World
Hello World We are excited to announce the official launch of evolue, a dynamic agile consultancy, that is committed to empowering organisations and individuals in navigating the ever-changing landscape of today's world. About Us:
MIP Discovery closes £7M Series A financing to drive commercialization in cell and gene therapy space
Company’s synthetic affinity reagents are antibody alternatives designed to advance the speed, safety, and efficiency of manufacturing at scale, making advanced therapies more accessible to patients. Investment led by Mercia Ventures, with Calculus Capital and Angel investors alsOptibrium enables collaborative design in its StarDrop platform
The new Idea Tracker capability further improves the efficiency of drug discovery by supporting project management, idea sharing and molecule design tracking The software promotes collaboration within and across teams for more cohesive workflows
'I was only doing my job'. No-one has the right to obey
High Performance Change writes...Subordination doesn't justify abdication. A Post Office investigator's defence that 'I was only doing my job' isn't enough. Interestingly, the skills you need to be able to look yourself in the mirror happen to be the same ones that underpin your ability to adapt.
Cambridge Science Centre welcomes new trustee to its Board
Harriet Fear, MBE, has recently joined the Cambridge Science Centre Board, bringing with her extensive expertise that complements the current Board's strengths, led by Dr David Cleevely.
ELRIG UK announces Steve Bates and Dr Anderson Ryan as Keynote Speakers at Research and Innovation 2024
ELRIG Research and Innovation 2024 takes place from 20–21 March in Manchester, UK Key topics include oncology, antimicrobial resistance, mass spectrometry, proteomics and animal-free drug discovery Launch of TechBio Breakthrough Zone offers youngInbiomotion and Source BioScience sign an exclusive agreement for MAF Test® in United Kingdom and Ireland
This pioneering test aids oncologists in predicting recurrence and survival rates in breast cancer patients and potential treatment eligibility to bisphosphonates Results showing the clinical utility of the test have been published in Lancet Oncology and the Journal of National CClosed Loop Medicine demonstrates application of novel drug plus software product for personalized treatment of hypertension
Study published in JAHA validates use of proprietary technology to identify personalized dose regimen, leading to improved blood pressure control and exceptionally high adherence in hypertension patients Findings will guide the Company’s strategy to expand portfolio of differentiBioPartner UK appoints Strategic Communications Specialist Dr Priya Kalia to Advisory Board
BioPartner UK, the independent, accredited trade organisation, announces the appointment of Dr Priya Kalia, Managing Director of SciTribe Ltd, to its Advisory Board. BioPartner UK’s Advisory Board includes senior investors, executive and non-executive directors, and business development executives. It is focused on driving awareness of global opportunities for small-to-medium enterprises and…
Applications are now open for Accelerate@Babraham
The programme, which each year offers five early-stage life science start-ups the chance to join the Babraham Research Campus community, brings to bear an unrivalled network of experts, mentors, investors, data-driven business support, lab space and funding to equip new enterprises with the skills, confidence, connections to enable success.